Renovaro Biosciences Inc. (RENB)
NASDAQ: RENB
· Real-Time Price · USD
0.36
0.05 (16.54%)
At close: Jun 09, 2025, 3:59 PM
16.54% (1D)
Bid | 0.3 |
Market Cap | 61.79M |
Revenue (ttm) | 181.45K |
Net Income (ttm) | -67.01M |
EPS (ttm) | -0.25 |
PE Ratio (ttm) | -1.44 |
Forward PE | n/a |
Analyst | n/a |
Ask | 0.4 |
Volume | 3,120,605 |
Avg. Volume (20D) | 2,364,422 |
Open | 0.32 |
Previous Close | 0.31 |
Day's Range | 0.31 - 0.37 |
52-Week Range | 0.27 - 2.34 |
Beta | 0.53 |
About RENB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RENB
Website n/a
4 weeks ago
-0.66%
RENB stock has given up its prior gain. Renovaro s...
Unlock content with
Pro Subscription
4 weeks ago
-0.66%
Renovaro shares are trading higher after the company announced its subsidiary, BioSymetrics, received a Notice of Allowance from the United States Patent and Trademark Office for a new patent application titled "Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions"